1 / 67



. . Parking Lot Care?. Case. 54 yr old F, 3D hx of N/V/D and abdo pain no fever no GI bleeding confused today Hx HTN metoprolol and ASA. Case. T 36.1 P 62 BP 99/60 RR 28 Sat 92% lethargic, weak, sl. confused dry MM, JVP flat, PPP

orrin
Download Presentation



An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 

  2. Parking Lot Care?

  3. Case • 54 yr old F, 3D hx of N/V/D and abdo pain • no fever • no GI bleeding • confused today • Hx HTN • metoprolol and ASA

  4. Case • T 36.1 P 62 BP 99/60 RR 28 Sat 92% • lethargic, weak, sl. confused • dry MM, JVP flat, PPP • abdo diffusely tender, no guarding/rebound • midline scar ? hx • stools OB +ve, no melena/blood

  5. Case Differential Diagnosis • gastroenteritis with dehydration • ischemic gut • intra-abdominal sepsis • urosepsis

  6. Case • chemstrip • monitored bed • IV’s • NS bolus/infusion • analgesic/antiemetic • Labs: CBC/CH6, coags, LFT’s/lipase, lactate

  7. Case glc 0.8 CBC • Hb 160 • plt 30 • WBC 24 (neuts) lytes • Na 141 • K 5.2 • Cl 96 • CO2 8 creatinine 123 lactate 22 LFTs • ALT >3000 • Bili 42 • ALP 105 Coags • INR >9 • PTT >150

  8. Acute Liver Failure Cathy Dorrington MD FRCPC

  9. Objectives • define, diagnose and to list common etiologies of Acute Liver Failure (ALF) • describe appropriate emergency management of ALF • be knowledgeable regarding predictors of prognosis in patients with ALF

  10. ALF Definition Pt with labs c/wHEPATITIS (15X N ALT) + COAGULOPATHY = INR >1.5 + Any ENCEPHALOPATHY + NO PRE-EXISTING liver disease + DURATION < 26 wks Polson and Lee. Hepatology 2005

  11. ALF Differential Diagnosis • Sepsis with DIC • Disease process involving brain and liver • SLE • TTP • Acute decompensation of chronic liver disease

  12. Prognosisoverall survival 65%1998-2001 N=308 Ostapowicz. Ann Intern Med 2002

  13. Etiology • Metabolic • Wilson’s • Drugs / Toxins • OTC - Tylenol • Prescription • Herbals • Illicit - Ecstasy • Amanita • Pregnancy • HELLP • Fatty Liver ACUTE LIVER FAILURE Autoimmune • Viral • HAV • HBV / HDV • Non-A-E • Infiltrative • Lymphoma • Melanoma • TB • Vascular • Budd-Chiari • Ischemic

  14. Etiology of ALF1998-2001 N=308 Ostapowicz. Ann Intern Med 2002

  15. Etiology Prescription Drugs* • isoniazid (16%) • propylthiouracil (9%) • phenytoin (7%) • valproic acid (7%) *unlikely if taken > 2 years Ostapowicz. Ann Intern Med 2002

  16. Investigations post diagnosis ALF • ammonia • fibrinogen level • APAP level /toxicology screen • viral hepatitis serology • anti-HAV IgM, HBsAg, anti-HBcIgM, anti-HEV, anti-HCV • ceruloplasmin level (Wilson’s) • autoimmune markers • ANA, ASMA, immunoglobulin levels • HIV - rapid Polson and Lee. Hepatology 2005

  17. Investigations Imaging • ultrasound abdomen with doppler • Budd-Chiari • malignant infiltration • tumour • cirrhosis (acute on chronic)

  18. Management • etiologic specific therapy • NAC in non-APAP ALF • metabolic disturbances • hemodynamics • management of complications • transplant consideration

  19. Management Etiology known • APAP -> NAC • autoimmune -> steroids • Budd-Chiari ->TIPS • malignant infiltration -> chemo • Hep B -> antivirals* • Amanita Phalloides ->silibinin/Pen G NOT recommended

  20. Management NAC in non-acetominophen ALF • improves microcirculatory tissue perfusion • inotrope • antioxidant • vasodilator • improves cerebral perfusion pressure

  21. Management NAC in non-APAP ALF: Gastroenterology 2009 • RCT 173 adult pts with ALF • excluded shock, malignancy, pregnancy • 72 hr infusion

  22. Management • 3wk survival similar • Transplant rate similar • transplant-free survival improved • 40% vs. 27% • benefit confined to Grade I/II : NNT 5

  23. Metabolic Disturbances • hypoglycemia • K+,  Mg++,  Na+, PO4 • lactic acidosis

  24. Hemodynamics of ALF • volume depletion • hyperdynamic circulation • maintenance of MAP >60 to CPP • pressor of your choice

  25. Coagulopathy • significant bleeding in 10-20% • upper GI • nasopharynx • skin puncture sites

  26. CoagulopathyNon-Bleeding Patients INR • DO NOT CORRECT with FFP unless planned invasive procedure • best prognostic feature • triage for transplant • Vitamin K 10mg for all Platelets • invasive procedures >50 • otherwise <10

  27. CoagulopathyBleeding Patient FFP • correct INR to ≤ 1.5 Vitamin K Platelets • correct to 50 Activated Factor VIIa • consider if INR not correcting with FFP Fibrinogen • cryoprecipitate if < 1 • 10 units

  28. CoagulopathyBleeding Patient ? Octaplex • not studied in this patient population • relative contraindication • risk of peri-operative thrombus • absolute contraindication • co-existent DIC

  29. Encephalopathy Grades of Encephalopathy I - Changes in behavior with minimal change in level of consciousness II - Gross disorientation, drowsiness, possibly asterixis, inappropriate behavior III - Marked confusion, incoherent speech, sleeping most of the time but arousable to vocal stimuli IV - Comatose, unresponsive to pain, decorticate or decerebrate posturing

  30. Encephalopathy • cerebral edema/increased ICP >> toxins • mental status -> tremor/asterixis • important predictor of survival • triage tool for transplant • CT head in altered pts to r/o bleed

  31. Encephalopathy Cerebral Edema • leading cause of death and disability • 50-85% in grades III/IV encephalopathy • poorly understood • cytotoxic accumulation of substances normally cleared by liver • vasogenic

  32. Ammonia & Cerebral Edema • metabolized by astrocytes to glutamine • accumulates in astrocytes to cause cell swelling Blei. Hepatology 2000

  33. Encephalopathy Lactulose • ? small increase in survival time • no change in degree of encephalopathy • no change in overall outcome Alba. J Hepatol 2002

  34. Management • bowel distension -> challenge to transplant

  35. Encephalopathy Sedation – avoid in Grade I/II • Benzos •  T½ -> encephalophathy evaluation • Propofol • first choice • ?decrease ICP • smaller doses as  T½

  36. Encephalopathy Seizures • phenytoin • low dose benzos during phenytoin load • no benefit to prophylactic administration Ellis. Hepatology 2000

  37. Encephalopathy Cerebral Edema (assume in Grade III/IV) • HOB 30° • barbituates (thiopental) • mannitol/hyperventprn • steroids not beneficial • ? cooling (32-34 C) • ?ICP monitor Polson and Lee. Hepatology2005

  38. Infection • 80% develop bacterial infection • 25% of exclusion for transplant • 40% post-transplant deaths • SIRS  worsening encephalopathy • fever worsens ICH Rolando. Hepatology 1990

  39. Infection • prophylactic antibiotics •  rate of infection (61% vs. 32%) •  but not stat sig Δ in mort (45% vs. 67%) • consider, low threshold for empiric tx • gut decontamination with po antibiotics • no change in rate of infection or outcomes Rolando. Hepatology 1993

  40. Infection • screening • culture all • asceptic technique • lines etc. • empiric if suspected • ceftriaxone plus vanco

  41. Renal Dysfunction • 42% - 82% of ALF • 75% APAP overdose • etiology • hypotension, hypovolemia • TNF, endotoxins • renal vasoconstriction • unfavourableprognosis

  42. Renal Dysfunction • replace/maintain volume • avoid nephrotoxic drugs • avoid contrast or NAC prior

  43. Disposition • ICU • hepatology consult • +/- transfer to transplant center Predicting prognosis and decision to transfer

  44. Prognosisoverall survival 65%1998-2001 N=308 Ostapowicz. Ann Intern Med 2002

  45. Prognosis • etiology • lab values

  46. Prognosis Etiologies with poor outcome = <25% spontaneous recovery • mushroom poisoning and Wilson’s: 0% • idiosyncratic drug injury • acute hepatitis B • autoimmune • Budd-Chiari syndrome • indeterminate Polson and Lee. Hepatology 2005

  47. Prognosis Etiologies associated with better outcomes = >50% spontaneous recovery • APAP (85%) • HAV • shock liver • pregnancy related Polson and Lee. Hepatology 2005

More Related